In addition, the results of combined genotype analysis of these two SNPs showed a borderline significant association between CYP3A4 and VDR Taq I combined variant genotypes and PRCa risk (RR=3.43; 95% CI=0.99–11.77).
← all excerpts
CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia.
2
—
—
The sentences
The RR of BPH patients developing PRCa was 2.7, although results failed to reach significance at the 5% level.